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ABSTRACT 
Redox processes are important in chemistry, with applications in biomedicine, chemical analysis, 
among others. As many redox experiments are also performed at a fixed value of pH, having an 
efficient computational method to support experimental measures at both constant redox 
potential and pH is very important. Such computational techniques have the potential to validate 
experimental observations performed under these conditions and to provide additional 
information unachievable experimentally such as an atomic level description of macroscopic 
measures. We present the implementation of discrete redox and protonation states methods for 
constant redox potential Molecular Dynamics (CEMD), for coupled constant pH and constant 
redox potential MD (C(pH,E)MD), and for Replica Exchange MD along the redox potential 
dimension (E-REMD) on AMBER. Validation results are presented for a small system that 
contains a single heme group: N-acetylmicroperoxidase-8 (NAcMP8) axially connected to a 
histidine peptide. The methods implemented allow one to make standard redox potential (Eo) 
predictions with the same easiness and accuracy as pKa predictions using the CpHMD and pH-
REMD methods currently available on AMBER. In our simulations we can correctly describe, in 
agreement also with theoretical predictions, the following behaviors: when a redox-active group 
is reduced the pKa of a near pH-active group increases because it becomes easier for a proton to 
be attached; equivalently, when a pH-active group is protonated the standard redox potential (Eo) 
of an adjacent redox-active group rises. Further, our results also show that E-REMD is able to 
achieve faster statistical convergence than CEMD or C(pH,E)MD. Moreover, computational 
benchmarks using our methodologies show high-performance of GPU accelerated calculations in 
comparison to conventional CPU calculations.  
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I. INTRODUCTION 
The coupling between electron and proton transfer is essential to describe many important 
biological processes. The protonation/redox state of proteins and other biomolecules is related to 
their structure and function, and it can affect properties like stability, ligand binding, catalysis, 
absorption spectrum, among others 1,2. This happens because the solution’s pH and redox 
potential (reduction potential or electrode potential) affect the charge distribution on the 
biomolecules due to changes in the predominant protonation/redox state of the titratable groups. 
For many systems, the standard redox potential (also called midpoint reduction potential) turns 
out to be pH-dependent 3,4. Hence, theoretical methods that can correctly describe systems at 
constant pH and constant redox potential are very important. Previous works in this area have 
been published 5–12. 
Due to the mathematical similarity between the Henderson-Hasselbalch equation (applied to 
acid-base reactions) and the Nernst equation (applied to electrochemistry, redox reactions), the 
theoretical derivations used on constant pH methods 13–16 can be extended to constant redox 
potential methods 17. There are two types of Constant pH Molecular Dynamics (CpHMD) 
approaches 18: the ones that consider continuous protonation states 19–22 and the ones that 
consider discrete protonation states 13,14. The continuous protonation states approach is based on 
the introduction of a fictitious particle at each titratable site that is propagated through 
conventional Molecular Dynamics (MD) according to a pH-dependent force. The discrete 
protonation states approach makes use of Metropolis Monte Carlo exchange attempts between 
different protonation states over the course of the MD. Regardless of the approach type, the 
accuracy of predicted pKa values relies not only on the accuracy of the force field parameters but 
also on the extent of the conformational sampling. 
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Replica Exchange Molecular Dynamics (REMD) is a state-of-the-art method that is able to 
significantly improve conformational sampling convergence 23–28 while taking advantage of 
computational parallelization. This approach consists of individual simulations (which are 
considered as independent replicas) that periodically attempt to exchange information between 
them through a Metropolis Monte Carlo scheme. Studies regarding REMD along the pH 
dimension (pH-REMD) have been reported in the literature 18,21,24,25,29,30. In pH-REMD, each 
replica explores the conformational space at a different pH value. 
In this work, we present the implementation of constant redox potential MD (CEMD), of coupled 
constant pH and constant redox potential MD (C(pH,E)MD), and REMD along the redox 
potential dimension (E-REMD) in the AMBER software package 31. To the best of our 
knowledge, this is the first implementation of E-REMD. Discrete redox and protonation states 
are considered in our methodologies, and calculations can be done using both implicit (i.e. 
Generalized Born, GB) or explicit solvent models. These new implementations are based on 
existing CpHMD and pH-REMD methods implemented on AMBER by Mongan, Swails, and 
others 13,18,25. We present results for N-acetylmicroperoxidase-8 (NAcMP8) 32 with a histidine 
peptide as the axial ligand. NAcMP8 is a small peptide derived from cytochrome c that has a 
single ferric heme group and is a good reference compound candidate for the simulation of larger 
proteins containing one or more equivalent heme groups. 
Previous simulations for large systems using AMBER’s high-performance GPU code have 
shown to have great speedups over calculations using conventional CPUs 33,34. Our CEMD, 
C(pH,E)MD and E-REMD implementations are also available using AMBER’s GPU code. To 
our knowledge, these are the first implementations of constant redox potential methods using 
GPU accelerated code. 
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II. THEORY AND METHODS 
A. Constant Redox Potential Molecular Dynamics (CEMD) 
In CEMD we make use of Monte Carlo transitions between discrete redox states, represented by 
different atomic charge distributions for reduced and oxidized states of a given redox-active 
residue. Further, in CEMD a predetermined number of MD steps are performed, the simulation is 
then halted, and a redox state change is attempted. In order to understand how the energetic cost 
of this attempt is computed, we start from the reduction reaction: 
 𝐴𝑜𝑥𝑖
𝑛+ + 𝑣𝑒−
     𝐾𝑒     
↔    𝐴𝑟𝑒𝑑
(𝑛−𝑣)
 ( 1 ) 
The equilibrium constant is given by 𝐾𝑒 =
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)
]
[𝐴𝑜𝑥𝑖
𝑛+ ][𝑒−]𝑣
 and is unitless. It is possible to devise 
expressions equivalent to 𝑝𝐻 = − log[𝐻+] and 𝑝𝐾𝑎 = − log𝐾𝑎 for the redox potential 𝐸 =
−
𝑘𝑏𝑇
𝐹
ln[𝑒−] and the standard redox potential 𝐸𝑜 =
𝑘𝑏𝑇
𝑣𝐹
ln(𝐾𝑒), where F is the Faraday constant. 
Then, from the equilibrium constant expression we get to the Nernst equation 35: 
 𝐸 = 𝐸
𝑜 +
𝑘𝑏𝑇
𝑣𝐹
ln
[𝐴𝑜𝑥𝑖
𝑛+ ]
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)]
 ( 2 ) 
From this equation, an expression for the fraction of reduced species is devised: 
 𝑓𝑟𝑒𝑑 =
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)]
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)] + [𝐴𝑜𝑥𝑖
𝑛+ ]
=
1
1 + 𝑒
𝑛
𝑣𝐹
𝑘𝑏𝑇
(𝐸−𝐸𝑜)
 ( 3 ) 
In this equation, 𝑛 is the Hill coefficient and is a post hoc correction added to account for the fact 
that the redox-active group might be affected by other pH- or redox-active groups nearby. We 
can also devise an expression for 𝑓𝑟𝑒𝑑 based on a statistical mechanics point of view: 
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 𝑓𝑟𝑒𝑑 =
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)]
[𝐴𝑟𝑒𝑑
(𝑛−𝑣)] + [𝐴𝑜𝑥𝑖
𝑛+ ]
=
𝑒
−𝐺𝑟𝑒𝑑𝑢𝑐𝑒𝑑
𝑘𝑏𝑇
𝑒
−𝐺𝑟𝑒𝑑𝑢𝑐𝑒𝑑
𝑘𝑏𝑇 + 𝑒
−𝐺𝑜𝑥𝑖𝑑𝑖𝑧𝑒𝑑
𝑘𝑏𝑇
=
1
1 + 𝑒
∆𝐺𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛
𝑘𝑏𝑇
 ( 4 ) 
The Gibbs Free Energy of reduction can be obtained from equations 3 and 4: 
 ∆𝐺𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 = 𝑣𝐹(𝐸 − 𝐸
𝑜) ( 5 ) 
Any theoretical modeling based solely on this equation requires prior knowledge of the 𝐸𝑜 value, 
however this is one of the properties one wants to be able to predict theoretically. To overcome 
this issue, we also write equation 5 for a reference compound where the value of 𝐸𝑜 is known. 
We also split the Gibbs Free Energy of reduction into electrostatic (Coulombic) and non-
electrostatic contributions: 
 ∆𝐺𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 = 𝑣𝐹(𝐸 − 𝐸
𝑜) = ∆𝐺𝑒𝑙𝑒𝑐 + ∆𝐺𝑛𝑜𝑛−𝑒𝑙𝑒𝑐 ( 6 ) 
 ∆𝐺𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛,𝑟𝑒𝑓 = 𝑣𝐹(𝐸 − 𝐸𝑟𝑒𝑓
𝑜 ) = ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 + ∆𝐺𝑛𝑜𝑛−𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 ( 7 ) 
The approximation made on AMBER is that ∆𝐺𝑛𝑜𝑛−𝑒𝑙𝑒𝑐 = ∆𝐺𝑛𝑜𝑛−𝑒𝑙𝑒𝑐,𝑟𝑒𝑓, which leads to: 
 ∆𝐺𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 = 𝑣𝐹(𝐸 − 𝐸𝑟𝑒𝑓
𝑜 ) + ∆𝐺𝑒𝑙𝑒𝑐 − ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 ( 8 ) 
This is the equation used on CEMD to perform Monte Carlo redox state change attempts. 
∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 is a precomputed quantity adjusted to reproduce the 𝐸𝑟𝑒𝑓
𝑜  value for the reference 
compound, and ∆𝐺𝑒𝑙𝑒𝑐 is computed on every redox state change attempt. ∆𝐺𝑒𝑙𝑒𝑐 is obtained by 
taking the difference between the electrostatic energy associated with the proposed and current 
redox states. 
B. Constant pH and Redox Potential Molecular Dynamics (C(pH,E)MD) 
In CpHMD, the core equation for protonation state change attempts 13,25,30, equivalent to 
equation 8, is: 
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 ∆𝐺𝑝𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑖𝑜𝑛 = 𝑘𝑏𝑇(ln 10)(𝑝𝐻 − 𝑝𝐾𝑎,𝑟𝑒𝑓) + ∆𝐺𝑒𝑙𝑒𝑐 − ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 ( 9 ) 
In our C(pH,E)MD implementation, protonation and redox state change attempts are performed 
separately, even if the attempts happen at the same MD step. The relation between protonation 
and redox processes comes naturally from the fact that a successful redox state change attempt 
will change the charges of a redox-active group and this change will thus affect the next 
protonation state change attempts of neighboring pH-active groups. Similarly, a successful 
protonation state change attempt will affect the next redox state change attempts of near redox-
active groups. 
C. Replica Exchange Molecular Dynamics along the Redox Potential dimension (E-REMD) 
The chemical potential 𝜇𝐴 associated to a substance A is defined as 𝜇𝐴 = 𝜇𝐴
𝑜 + 𝑘𝑏𝑇 ln 𝑎𝐴 , where 
𝜇𝐴
𝑜 is the standard chemical potential and 𝑎𝐴 is the activity of A. The standard chemical potential 
for electrons is chosen as 𝜇𝑒−
𝑜 = 0, thus by making use of 𝐸 = −
𝑘𝑏𝑇
𝐹
ln[𝑒−] we obtain: 
 𝜇𝑒− = 𝑘𝑏𝑇 ln[𝑒
−] = −𝐹𝐸 ( 10 ) 
This shows that performing simulations at constant redox potential is the same as performing 
simulations at constant chemical potential for electrons (𝜇𝑒−). 
Hereafter, we show how the Monte Carlo exchange criterium derived by Itoh et al. 30 for pH-
REMD can be extended to E-REMD. First, we consider a system of M non-interacting replicas. 
Replica 𝑖 (𝑖 = 1,… ,𝑀) has coordinate and momentum vectors ?⃗?𝑖 and ?⃗?𝑖, temperature T, a redox 
potential value of 𝐸𝑙 (𝑙 = 1,… ,𝑀), and 𝑁𝑖
𝑒− electrons. If we exchange two replicas, the 
following detailed balance condition must be satisfied: 
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𝑃(𝑋𝑖
𝑙)𝑃(𝑋𝑗
𝑛)𝑤(𝑋𝑗
𝑛 → 𝑋𝑖
𝑛, 𝑋𝑖
𝑙 → 𝑋𝑗
𝑙) = 
𝑃(𝑋𝑖
𝑛)𝑃(𝑋𝑗
𝑙)𝑤(𝑋𝑗
𝑙 → 𝑋𝑖
𝑙, 𝑋𝑖
𝑛 → 𝑋𝑗
𝑛) 
( 11 ) 
where 𝑋𝑖
𝑙 ≡ (?⃗?𝑖 , ?⃗?𝑖, 𝑁𝑖
𝑒− , 𝐸𝑙), 𝑃 is the equilibrium probability, and 𝑤 is the transition probability. 
In the semi-grand canonical ensemble of electrons, where the volume (𝑉), temperature (𝑇), and 
𝜇𝑒− are fixed, the equilibrium probability is given by: 
 𝑃(𝑋𝑖
𝑙) =
1
Ξ
𝑒[−𝜀𝑖+(𝜇𝑒−)𝑁𝑖
𝑒−] 𝑘𝑏𝑇⁄ =
1
Ξ
𝑒[−𝜀𝑖−𝐹𝐸𝑙𝑁𝑖
𝑒−] 𝑘𝑏𝑇⁄  ( 12 ) 
where 𝜀𝑖 is the energy of the system, and Ξ is the grand canonical partition function. We can 
write the ratio of the transition probabilities as: 
 
𝑤(𝑋𝑗
𝑛 → 𝑋𝑖
𝑛, 𝑋𝑖
𝑙 → 𝑋𝑗
𝑙)
𝑤(𝑋𝑗
𝑙 → 𝑋𝑖
𝑙 , 𝑋𝑖
𝑛 → 𝑋𝑗
𝑛)
= 𝑒−Δ ( 13 ) 
 Δ =
𝐹
𝑘𝑏𝑇
(𝐸𝑛 − 𝐸𝑙)(𝑁𝑖
𝑒− − 𝑁𝑗
𝑒−) ( 14 ) 
The Metropolis Monte Carlo solution for the exchange probability can be then written as: 
 𝑤(𝑋𝑗
𝑚,𝑛 → 𝑋𝑖
𝑚,𝑛, 𝑋𝑖
𝑘,𝑙 → 𝑋𝑗
𝑘,𝑙) = {
1, Δ < 0
𝑒−Δ, Δ ≥ 0
 ( 15 ) 
It is important to notice that the acceptance ratio decreases exponentially with the difference in 
redox potential values. Therefore, it is important to choose redox potential values for the replicas 
such that the acceptance ratio is not too low. For example, for 𝑇 = 300 𝐾, 𝑁𝑖
𝑒− − 𝑁𝑗
𝑒− = 1 and 
𝐸𝑛 − 𝐸𝑙 = 30 mV we have 𝑒
−Δ ≅ 31%. Roughly the same probability is obtained on pH-REMD 
by using pH intervals of 0.5. This is already expected because it can be shown that 1.0 pH unit is 
equivalent to 59.5 mV in redox potential units at 𝑇 = 300 𝐾. 
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D. Theoretical description of the pH dependence of 𝑬𝒐 and the redox potential dependence 
of 𝒑𝑲𝒂 values 
By making use of a thermodynamic cycle, it is possible to devise equations to describe the pH 
dependence of standard Redox Potential 𝐸𝑜 and the redox potential dependence of 𝑝𝐾𝑎 values. 
This thermodynamic cycle and the derivations for all the equations shown in this subsection are 
available at the Supporting Information. By making thermodynamic considerations and assuming 
the system to contain only a single redox-active residue and one or more pH-active residues, we 
obtain: 
 𝑣𝐹(𝐸𝑝𝑟𝑜𝑡
𝑜 − 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜 ) = 𝑘𝑏𝑇 ln(10)∑(𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖) − 𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖) )
𝑖
 ( 16 ) 
where 𝐸𝑝𝑟𝑜𝑡
𝑜  and 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜  are the standard redox potential of the redox-active residue when all the 
pH-active residues are, respectively, fully protonated or fully deprotonated, and  𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖)
 and 
𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
 are the 𝑝𝐾𝑎 values of the 𝑖
𝑡ℎ pH-active residue when the redox-active residue is, 
respectively, fully reduced or fully oxidized. 
Equation 16 shows that the difference between 𝐸𝑝𝑟𝑜𝑡
𝑜  and 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜  is directly related to 
differences between 𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖)
 and 𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
. As an example of that, if the pH-active groups don’t 
suffer from the interaction with the redox-active group such that 𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖) = 𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
 then 
according to equation 16 we must necessarily have 𝐸𝑝𝑟𝑜𝑡
𝑜 = 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜 . 
We can also, in the following equation, describe the pH-dependent 𝐸𝑜 value for the case where 
the species of all pH-active residues are not all fully protonated nor all fully deprotonated: 
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 𝐸𝑜 = 𝐸𝑝𝑟𝑜𝑡
𝑜 +
𝑘𝑏𝑇
𝑣𝐹
∑ln(
10−𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖)
+ 10−𝑝𝐻
10−𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
+ 10−𝑝𝐻
)
𝑖
 ( 17 ) 
We observe that at the low pH limit (i.e., large [𝐻+] values) 𝐸𝑜 becomes 𝐸𝑝𝑟𝑜𝑡
𝑜  , and at the high 
pH limit (i.e., small [𝐻+] values) 𝐸𝑜 becomes exactly the expression for 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜  that we obtain 
from equation 16. 
The redox potential dependence of the 𝑝𝐾𝑎 values of the pH-active residues can be described by 
the following equation: 
 ∑𝑝𝐾𝑎
(𝑖)
𝑖
=∑𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖)
𝑖
+ log(
𝑒
−
𝑣𝐹𝐸𝑝𝑟𝑜𝑡
𝑜
𝑘𝑏𝑇
⁄  
+ 𝑒
−𝐹𝐸 𝑘𝑏𝑇
⁄  
𝑒
−
𝑣𝐹𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜
𝑘𝑏𝑇
⁄  
+ 𝑒
−𝐹𝐸 𝑘𝑏𝑇
⁄  
) ( 18 ) 
where 𝑝𝐾𝑎
(𝑖)
 is the redox potential dependent 𝑝𝐾𝑎 value of the 𝑖
𝑡ℎ pH-active residue. In the limit 
of high redox potential values (i.e., small [𝑒−] values) 𝑝𝐾𝑎
(𝑖)
 becomes 𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
 and equation 18 
turns into equation 16. 
III. CALCULATION DETAILS 
In this work, all the simulations were performed using an in-house modified version of AMBER 
16 31. Our implementations are part of the new AMBER 18 release. In this section we are going 
to discuss the C(pH,E)MD and E-REMD implementations, followed by details about 
parametrization of our test system, and the implicit and explicit solvent calculations performed. 
A. C(pH,E)MD implementation 
Previous discrete protonation states CpHMD publications have analyzed, among other things, the 
behavior of 𝑝𝐾𝑎 predictions in long Generalized Born (GB) implicit solvent simulations 
18. Also, 
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how a higher frequency of exchange attempts affects convergence on pH-REMD 25, and how 
variables like the solvent relaxation time affects explicit solvent simulations 18. These 
discussions will be revisited here in the context of constant redox potential, even though we 
expect to see these same behaviors due to the natural likeness between CpHMD and CEMD. 
This likeness can be seen by comparing equations 8 and 9 and arises from the similarities 
between the Henderson-Hasselbalch and the Nernst equations. 
Figure 1 shows the workflow of C(pH,E)MD as implemented in AMBER. The number of 
standard MD steps between state change attempts is tunable and may be different for protonation 
and redox state change attempts. Thus, protonation and redox state change attempts may happen 
at the same MD step. In this case the protonation state change attempts are performed first. 
 12 
 
Figure 1. C(pH,E)MD workflow as implemented on AMBER. This workflow generalizes both 
the implicit and explicit solvent implementations. 
In both the implicit and explicit solvent implementations, the proposed state of a residue in a 
protonation or redox state change attempt is chosen randomly from the available states of the 
residue, excluding the current state the residue is in. 
1. Implicit solvent (IS) implementation 
When the standard MD is halted for a protonation and/or redox state change attempt (see Figure 
1), a single residue is picked randomly and is the only residue considered for a protonation or 
redox state change attempt. 
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2. Explicit solvent (ES) implementation 
In the ES implementation, when the MD is halted one state change is attempted for each pH- 
and/or redox-active residue. The residues are chosen in random order until all pH- and/or redox-
active residues are visited once. Likewise the ES CpHMD AMBER implementation 18, during 
redox state change attempts the water molecules and any eventual ions are stripped and the 
∆𝐺𝑒𝑙𝑒𝑐 term for a redox-active residue (see equation 8) is computed using a GB model. After the 
attempts for each residue are performed, the solvent molecules are restored. If any state change 
was accepted, then solvent relaxation is performed. Solvent relaxation consists on performing a 
predetermined number of MD steps only on the degrees of freedom associated to the solvent, 
including any possible ions, while the solute degrees of freedom are kept fixed. Solvent 
relaxation is done to adapt the solvent conformation to the new protonation and/or redox state. 
The number of solvent relaxation steps may be different for protonation and redox state change 
attempts. In order to make C(pH,E)MD more efficient, if a protonation and a redox state change 
attempt happen at the same MD step when the standard MD is halted (see Figure 1), only a 
single solvent relaxation is performed using either the number of relaxation steps for protonation 
or redox state change attempts, whichever is larger. This actually makes the computational cost 
of C(pH,E)MD close to CpHMD or CEMD in ES simulation, as shown in the section IV.D.  
Doing one attempt for each residue when the simulation is halted allows us to perform 
protonation and redox state change attempts less frequently than in the IS implementation, thus 
lowering the total number of solvent relaxation steps over the course of the simulation. In ES 
constant pH and/or constant redox potential MD simulations, the solvent relaxation contributes 
the most to the computational cost of the methodology in comparison to regular MD. Therefore, 
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lowering the total number of relaxation steps makes the simulation computationally more 
efficient. 
During protonation or redox state change attempts, the sudden change in charge, even if the pH- 
or redox-active residue is not solvent exposed, destabilize the solvent molecules around the 
solute. This makes the use of ES calculations for state change attempts unfeasible as an 
unfavorable energy change would lead to a low state change probability. For this reason, our 
state change attempts require the use of implicit solvent calculations where the solvent 
instantaneously adapts to the new charge set. Stern 15 has proposed an ES CpHMD method that 
uses an interpolation between the current and the proposed protonation states and doesn’t require 
the use of implicit solvent calculations, but its implementation has not been attempted in the 
present publication. 
Another point worth to discuss is the fact that the net charge of the system changes when 
protonation or redox state change attempts are accepted. It has been shown that when periodic 
boundary conditions are in place and the electrostatic interactions are computed using a lattice 
sum, finite-size effects arise on simulations where the volume or the net charge is changing 
throughout the simulation 36,37. These effects have been shown to be higher for small unit cells 
and could lead to unrealistic behaviors 36. By using GB calculations for state change attempts in 
our methodology, we avoid these finite-size effects. In our implementation, the standard MD 
runs between state change attempts are done at constant charge. 
B. E-REMD implementation 
In replica exchange simulations, an important variable is the exchange attempt frequency (EAF). 
If the EAF equals zero, this means that no exchange attempts between replicas are performed and 
 15 
E-REMD becomes equivalent to C(pH,E)MD, or to CEMD if the constant pH option is not 
considered. Previous AMBER replica exchange publications have shown that by increasing the 
EAF the sampling convergence could be improved as the simulated system may overcome 
barriers more easily 25,38,39. In this work, we show that a better convergence is also obtained for 
E-REMD on properties that depend on the redox potential in comparison to C(pH,E)MD or 
CEMD. 
As can be seen in equations 14 and 15, the E-REMD exchange probability depends on the 
difference between redox potential values of the replicas we are trying to exchange. Therefore, in 
the same way that is done in AMBER for pH-REMD, in our E-REMD implementation we only 
attempt exchanges between replica neighbors to increase the exchange probability. To 
exemplify, consider 4 replicas ordered by increasing values of redox potential. At the first 
exchange attempt, we attempt to exchange replicas 1 with 2 and 3 with 4. On the next exchange 
attempt, the attempts are made between replicas 2 with 3 and 1 with 4. This cycle is repeated 
until the end of the simulation is reached. 
C. NAcMP8 parametrization 
In many proteins containing heme groups, each iron atom at the center of the porphyrin rings is 
axially connected to two histidines 11,40,41. For the theoretical modeling of such proteins, it is 
ideal to have a reference compound in agreement with this conformation. The standard redox 
potential of N-acetylmicroperoxidase-8 (NAcMP8) axially connected to an imidazole molecule 
has been experimentally measured as -203 mV vs. NHE at pH 7.0 32. NAcMP8 has a histidine 
residue from its peptide chain that is axially connected to the heme group. On the other side of 
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the porphyrin plane, we axially connected a histidine peptide as shown in Figure 2. This closely 
represents the experimental situation. 
 
Figure 2. N-acetylmicroperoxidase-8 (NAcMP8) with a histidine peptide as the axial ligand. The 
residue HEH is shown in green and the two propionates are shown in red. The glutamate is 
shown in blue. 
The structure of NAcMP8 is sketched in the Figure 1 of reference 32. From this figure and by 
making modifications to the structure of the horse heart cytochrome c 42 available at the PDB 
code 1HRC, we obtained the structure shown in Figure 2. The iron atom, the porphyrin ring, 
together with the side chains of two histidines and two cysteines were considered as a single 
residue we called HEH, which is colored in green at Figure 2. HEH is the redox-active residue 
that changes its atomic charge distribution when a redox state change attempt is successful. 
Therefore, a redox state change affects the charge distribution on the histidines and cysteines. 
 17 
The charge distributions of the reduced and oxidized states of HEH can be found at Table S1 in 
the Supporting Information. NAcMP8 contains three pH-active residues: two propionates (PRN) 
colored in red in Figure 2, and one glutamate (GL4) colored in blue. The propionates are separate 
residues from HEH. The charge distributions of the deprotonated and protonated states of PRN 
can be found at Table S2. 
Residues other than the heme group were parametrized using the AMBER FF99SB force field 43. 
The heme force field parameters were taken from Crespo et al. 44, with the atomic charges for the 
reduced and oxidized states adapted from Henriques et al. 40. The experimental pKa of a 
propionic acid is 4.85 45. The ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 term from equation 9 was fitted in implicit and explicit 
solvent constant pH simulations of a propionic acid in water using 𝑝𝐾𝑎,𝑟𝑒𝑓 = 4.85. The fitted 
value was then used in the simulations for the NAcMP8 propionates. ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 from equation 8 
for the HEH residue was also fitted in IS and ES using constant pH and redox potential 
simulations of NAcMP8 with a histidine peptide as the axial ligand with pH = 7.0 and 𝐸𝑟𝑒𝑓
𝑜 =
−203 mV. The glutamate residue has 𝑝𝐾𝑎,𝑟𝑒𝑓 = 4.4 and we used values already available in 
AMBER’s cpinutil.py tool for its ∆𝐺𝑒𝑙𝑒𝑐,𝑟𝑒𝑓 in IS and ES 
25. 
In the explicit solvent calculations, the intrinsic solvent radius of the carboxylate oxygens on the 
propionates and the glutamate was changed from 1.5 to 1.3 Å in order to compensate for having 
two dummy hydrogens present on each oxygen 18,46. 
D. Implicit Solvent Calculations 
We begin with the initial structure having the heme group in the oxidized state, and both 
propionates and the glutamate in the deprotonated state. This structure is then minimized for 100 
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steps using the steepest descent algorithm and then for 3900 steps using the conjugate gradient 
algorithm constraining the backbone atoms with a 10 kcal/mol·Å2 constant. The minimized 
structure is then heated during 3 ns by varying linearly the target temperature from 10 to 300 K 
over the initial 0.6 ns. During heating, the backbone atoms were constrained using a constant of 
1 kcal/mol·Å2, and the temperature was controlled using Langevin dynamics with a friction 
frequency of 5 ps-1. 
An equilibration at 300 K is then performed on the heated structure for 10 ns using Langevin 
dynamics with a 10 ps-1 friction frequency and a 0.1 kcal/mol·Å2 constrain on the backbone 
atoms. This equilibrated structure was used as the initial structure for the production simulations 
from where our results were extracted. For the production simulations, no positional restraints 
are applied and redox and/or protonation state change attempts are performed every 10 fs. 
Calculations with E-REMD were done using an exchange attempt frequency (EAF) of either 0.5 
or 50 ps-1, meaning one exchange attempt every 2000 or 20 fs respectively. All simulations were 
done with a time step of 2 fs and all bond lengths of bonds containing hydrogen atoms were 
constrained using the SHAKE algorithm 47,48. 
Previous AMBER implicit solvent CpHMD publications 13,18,25 have used the Generalized Born 
model proposed by Onufriev et al. 49 (represented by the input flag igb=2 on AMBER) to 
account for solvent effects. For consistency, the same model was used in our implicit solvent 
simulations, both during MD and during protonation and redox state change attempts. 
E. Explicit Solvent Calculations 
In the initial structure, the heme group is in the oxidized state, and both propionates and the 
glutamate are in the deprotonated state. The system was solvated using TIP3P waters in a 
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truncated octahedron box with a buffer of 10 Å (distance between the wall and the closest atom 
in the solute). In order to neutralize the total charge at this initial state, two sodium ions were 
randomly added to the solution. 
The initial structure was minimized, constraining the backbone atoms with a 10 kcal/mol·Å2 
constant, for 1000 steps using the steepest descent algorithm followed by 4000 steps of conjugate 
gradient. The minimized structure was then heated at constant volume during 3 ns using a 
backbone constrain of 1 kcal/mol·Å2 and Langevin dynamics with a friction frequency of 5 ps-1 
to control the temperature. During heating, the target temperature was linearly varied from 10 to 
300 K over the initial 0.67 ns.  
The heated structure was then equilibrated at constant pressure (1 bar) and temperature (300 K) 
for 8 ns with no backbone restraints, using a friction coefficient of 2 ps-1 for the Langevin 
dynamics to maintain the temperature and relaxation time of 3 ps for the Berendsen barostat to 
control the pressure. The system was then submitted to a new equilibration at constant volume 
and temperature (300 K) for 20 ns using Langevin dynamics with a 2 ps-1 friction frequency. The 
structure from this equilibration was used as input for the production simulations from where our 
results were extracted. 
It has been shown for ES CpHMD that when a protonation state change is accepted, relaxation 
times up to 4 ps could be required to completely stabilize the solvent, however, the most 
significant part of the solvent stabilization is done during the first 200 fs 18. As relaxation times 
on the order of 4 ps would have very significant effects on the computational cost of the 
methodology, lower computational relaxation times of around 200 fs were attempted. No 
significant differences were observed in the pKa predictions in comparison to higher relaxation 
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times of up to 2 ps. We verified this same behavior in ES CEMD or C(pH,E)MD on Eo 
predictions. 
In our production simulations, redox and/or protonation state change attempts are performed 
every 200 fs, and the solvent relaxation is performed for 200 fs. The E-REMD calculations were 
performed using an Exchange Attempt Frequency (EAF) of either 0.5 or 5 ps-1; this means one 
exchange attempt every 2000 or 200 fs respectively. The time step used on all MD simulations, 
including during solvent relaxation, is 2 fs and all bonds containing hydrogen atoms were 
constrained using the SHAKE algorithm 47,48. The particle-mesh Ewald method 50,51 using a van 
der Waals cutoff and a direct space of 8 Å was considered for the long-range electrostatic 
interactions. 
As discussed in the section III.A, the redox and protonation state change attempts are performed 
in implicit solvent. In our explicit solvent calculations, we also use the GB model proposed by 
Onufriev et al. 49 (igb=2 on AMBER) for that. 
IV. RESULTS AND DISCUSSIONS 
As discussed before, replica exchange simulations are meant to accelerate convergence. This 
means a REMD simulation should converge faster than a simulation without REMD for the same 
number of steps. We will now test this concept for E-REMD by presenting results for short 
simulations in which neither the CEMD nor C(pH,E)MD results are converged, and also evaluate 
what happens as a function of simulation time on long simulations. We then analyze how the use 
of E-REMD affects the results. 
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A. CEMD vs E-REMD 
1. Short simulations 
CEMD results are presented for simulations in which the propionates and the glutamate are both 
either protonated or deprotonated throughout the whole simulation, including during 
minimization, heating and equilibration. Production simulations were executed for only 50 ps 
(25,000 MD steps) in IS and 1000 ps (500,000 MD steps) in ES. As discussed previously, we are 
making protonation and redox state change attempts every 10 fs in IS and every 200 fs in ES. For 
this reason, significantly more state change attempts are performed in IS than in ES during the 
same simulated time interval. In order to account for that, we are performing more steps for ES 
than for IS in this analysis. 
Production simulations were performed for 12 values of redox potential, using CEMD and also 
E-REMD with two different EAFs. Figure 3 shows the fraction of reduced species of HEH as a 
function of E, and the fittings of Eo and Hill coefficient using equation 3 to the data obtained 
from the simulations. The errors reported for Eo and Hill coefficient are the errors in the fitting to 
equation 3. Results are shown for both implicit and explicit solvent models. 
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Figure 3. Fraction of reduced species of HEH as a function of the redox potential for short 
constant redox potential simulations: 50 ps in IS and 1000 ps in ES. The pH-active residues are 
either all deprotonated or protonated throughout the whole simulation. EAF = Exchange Attempt 
Frequency. 
The fractions of reduced species obtained from the simulations are in agreement with the 
expected behavior predicted by equation 3. Lower fitting errors are obtained when replica 
exchange is used. 
A protonation of a pH-active group leads to a positive increase on its charge. Hence, as electrons 
can neutralize the positive charge of protons, the standard redox potential of an adjacent redox-
active group increases as it becomes easier for an electron to be attached there. The standard 
redox potentials shown in Figure 3 have more positive Eo values when all pH-active residues are 
protonated in comparison to when they are all deprotonated, therefore in agreement with the 
expectation. 
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B. C(pH,E)MD vs E-REMD 
1. Short simulations 
We now extend the same test from the previous section to C(pH,E)MD, and, starting from the 
equilibrated structure where the propionates and the glutamate are deprotonated, we let their 
protonation states change during the production simulations while still allowing the redox states 
to change as before. Here, production simulations were executed for only 50 ps in IS and 1000 ps 
in ES, and for 18 different pH values ranging from 2.0 to 10.5 in intervals of 0.5. Further, for 
each pH value, 12 values of redox potential from −353 to −23 mV with interval of 30 mV were 
considered. Results are shown for C(pH,E)MD and E-REMD with two different EAFs, where in 
E-REMD only replicas with the same pH are allowed to have their redox potential values 
exchanged. For each pH, we plotted the fraction of reduced species versus redox potential (as in 
Figure 3) to extract the value of Eo. Then, the Eo of HEH as a function of pH is shown in Figure 
4. Results are shown for both implicit and explicit solvent models. 
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Figure 4. Standard redox potential (Eo) of HEH as a function of pH for short simulations: 50 ps 
in IS and 1000 ps in ES. Dots are from the simulations and the solid curves are the fittings using 
equation 17. EAF = Exchange Attempt Frequency. 
As the pH of the solution increases, the concentration of deprotonated species increases, leading 
to lower values of Eo as it becomes more energetically unfavorable for an electron to reduce the 
heme group. This behavior has been reported experimentally 3,4. Further, it can be seen that the 
most significant changes in Eo with respect to pH happen for pH values around the pKas of the 
pH-active residues that more closely interact with the redox-active residue. The results shown in 
Figure 4 are in agreement with these trends. The solid curves are the fittings of the data from the 
simulations to equation 17. As can be seen in figure 4, this equation clearly describes the pH-
dependence of Eo values observed in our simulations. Also, the low and high pH limits Eo values 
matches with the Eo values predicted in the previous section using CEMD for all protonated and 
all deprotonated pH-active residues, respectively. 
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2. Long simulations 
Here, we analyze how our standard redox potential predictions behave as a function of 
simulation time for C(pH,E)MD and E-REMD. In some situations, like for the study of processes 
that happen at long time scales, long simulations must be performed and, due to computational 
efficiency limitations, GPU-accelerated CUDA calculations must be used. Therefore, the 
analysis to be shown here demonstrate if our methodologies are stable and can be used in these 
situations. 
For this analysis, production simulations were executed for 300 ns in both IS and ES. Both the 
Single Precision Fixed Point (SPFP) and the Double Precision Fixed Point (DPFP) AMBER 16 
CUDA precision models 52 were used for the IS calculations, and only SPFP was used for the ES 
calculations. By construction, the CUDA DPFP implementation contains no further 
approximations in comparison to the CPU code and is the precision model used in AMBER to 
directly compare CPU and GPU results. Simulations were performed for pH = 7.0 and 12 redox 
potential values from -353 to -23 mV. The cumulative fraction of reduced species for each redox 
potential value was obtained as a function of time, and for each time we gathered all the fractions 
to fit Eo using equation 3. The cumulative prediction of the Eo of HEH as function of simulation 
time can then be obtained. This procedure was independently repeated 5 times. Figure 5 contains 
the average for the 5 independent simulations of the cumulative Eo as a function of simulation 
time. We also report the standard deviation of the Eo predictions in the 5 independent simulations 
as a function of time. Results are presented for C(pH,E)MD and E-REMD with three different 
EAFs, for both IS and ES calculations. 
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Figure 5. Cumulative standard redox potential (Eo) of HEH averaged for 5 independent 
simulations (top) and its standard deviation (bottom) as a function of time for pH 7.0. EAF = 
Exchange Attempt Frequency; SPFP = Single Precision Fixed Point; DPFP = Double Precision 
Fixed Point. 
The standard deviations in the Eo predictions can be interpreted as an error measure of our 
methodologies. For both implicit and explicit solvent simulations, we observe that the 
C(pH,E)MD and E-REMD predictions agree with each other within the errors reported. The 
significantly lower errors for E-REMD in comparison to C(pH,E)MD are a very compelling 
evidence of the better convergence efficiency of E-REMD. It is also important to emphasize that 
the error bars obtained are reasonably small. We see error bars of up to 2.7 mV for C(pH,E)MD 
and of up to 1.2 mV for E-REMD. At 300 K these values correspond to 0.045 and 0.020 in pH 
units, respectively. 
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To complement the analyses done from Figure 5, in Figure 6 we split the simulations into 5 ns 
chunks and compute the predicted Eo of each window using the fractions of reduced species for 
all redox potential values. Figure 6 was also generated using data from the 5 independent runs. 
 
Figure 6. Chunk standard redox potential (Eo) of HEH averaged for 5 independent simulations 
(top) and its standard deviation (bottom) computed for windows of 5 ns as a function of time for 
pH 7.0. EAF = Exchange Attempt Frequency; SPFP = Single Precision Fixed Point; DPFP = 
Double Precision Fixed Point. 
Figure 6 also confirms smaller standard deviations for E-REMD simulations in comparison to 
C(pH,E)MD. In some cases, we also observe that the chunk Eo predictions are clearly different at 
the beginning and at the end of the simulation, which means the chunk Eo values do not fluctuate 
anymore around the target value of -203 mV. This explains the Eo drops observed in Figure 5 
generally after 200 ns of simulation. In order to understand this behavior, we looked at one of the 
C(pH,E)MD IS SPFP independent runs. For this simulation, we concluded the Eo drop is caused 
by a conformational change (a flip) in the histidine that belongs to the NAcMP8 peptide chain. 
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The side chain of this histidine is part of the HEH residue (see Figure 2). More details and 
discussions about this are provided at section IV of the Supporting Information. As we show in 
the Supporting Information, even if this conformational change happens for only one of the 
redox potential values close to Eo, this is already enough to affect the Eo fitting. In the simulation 
analyzed, this conformational change happened only once throughout the 300 ns simulated. 
Therefore, the addition of redox potential replica exchange helps to mix different conformations 
across different target redox potential values, which possibly explains the fact that the Eo drops 
in Figures 5 and 6 are more subtle for E-REMD than for C(pH,E)MD. 
Previous AMBER replica exchange publications have shown that increasing EAF in T-REMD 
simulations improves the convergence in structural analyzes due to the better sampling of the 
conformational space 39. For pH-REMD, where a better sampling of the pH-space is done, better 
convergence in the pKa prediction for some residues are obtained when EAF is increased 
25. In 
this pH-REMD paper this conclusion about increasing EAF is reached mostly based in the results 
for a single residue, Asp 66. The authors, Swails et al., attribute this behavior for Asp 66 to a 
better mobility of flexible regions of the protein they studied (HEWL). As can be seen in their 
paper, excluding Asp 48, all the other pH-active residues are effectively insensitive to increasing 
the EAF. 
As can be seen in both Figures 5 and 6, the standard deviations in the E-REMD simulations do 
not change significantly when we increase EAF from 0.005 ps-1 to higher values. C(pH,E)MD 
corresponds to the limit of EAF equal to zero, therefore if we decrease EAF to values below 
0.005 ps-1 we must at some point start seeing the same behavior observed for C(pH,E)MD. 
However, as can be seen, even the small EAF of 0.005 ps-1 (where 1500 exchange attempts are 
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performed during 300 ns of simulation) was enough to see effectively the same behavior 
observed for the higher EAF used. 
Another important discussion to be done here has to do with the fact that systems containing at 
least a single heme group were not included during the parametrization of the GB model 
proposed by Onufriev et al. 49 (igb=2 on AMBER) used in this paper. Thus, the iron ion is the 
only heme atom without specific GB parameters. In our simulations we used the values 1.5 and 
0.8 Å for the iron GB radius and screen, respectively. In the explicit solvent simulations, we see 
that the water molecules are always more than 4 Å apart from the iron atom, as can be seen at 
Figure S2 at the Supporting Information. As the iron ion is then nearly buried, one would expect 
that the exact values for these GB parameters will not influence the simulation results 
significantly. Also, it is important to check whether the porphyrin ring and the iron ion remain 
planar over the course of the implicit simulations. As the data in section II of the Supporting 
Information shows, we observe that both the porphyrin ring and the iron ion remain planar in 
both the implicit and the explicit solvent simulations. The dihedral angles analyzed obtained in 
implicit solvent are close to the values obtained in explicit solvent. 
C. Predicting Eo vs pH and pKa vs E 
As discussed in the section IV.B.1, Eo should decrease with the increase of the solution pH. 
Following the same reasoning, equivalently the pKa of a pH-active residue should also decrease 
with the increase of the solution redox potential. Based on the discussions from Figures 5 and 6, 
we present 140 ns production simulation results in both IS with CUDA DPFP and in ES with 
CUDA SPFP. We have used E-REMD with EAF = 5 ps-1 in ES and EAF = 50 ps-1 in IS, 18 
different pH values from 2.0 to 10.5, and for each pH value 12 values of redox potential from 
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−353 to −23 mV were considered. Figure 7 shows the standard redox potential of HEH as a 
function of pH, and the pKa of all pH-active residues and their sum as a function of the redox 
potential for both implicit and explicit solvent simulations. The solid lines in the figure are 
fittings using equations 17 and 18. 
 
Figure 7. Standard redox potential (Eo) of HEH as a function of pH, and pKa values of the pH-
active residues as a function of the redox potential. The solid lines are fittings using equations 17 
and 18 to the data from the simulations. E-REMD simulations are 140 ns long in IS (CUDA 
DPFP) and ES (CUDA SPFP) respectively. EAF = Exchange Attempt Frequency; GL4 = 
Glutamate; PRN = Propionate 
As Figure 7 shows, we obtain a very good agreement between the theoretical predictions from 
equations 17 and 18 and the data from the simulations. It is important to mention that if we 
simply get the parameters in the equations (𝐸𝑝𝑟𝑜𝑡
𝑜 , 𝐸𝑑𝑒𝑝𝑟𝑜𝑡
𝑜 , 𝑝𝐾𝑎,𝑟𝑒𝑑
(𝑖)
 and 𝑝𝐾𝑎,𝑜𝑥𝑖
(𝑖)
) from the 
simulations, thus without fitting, we already obtain a good description of the simulation data 
shown in Figure 7. We also observe, as one would expect from the equations, that the pH values 
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for which the Eo of HEH changes the most are around the pKa values of the pH-active groups 
that more closely interact with the heme group. Equivalently, the pKa of each pH-active residue 
changes the most for redox potential values around the Eo of HEH. As the figure shows, the pKa 
values of the two propionates are not exactly the same. They actually differ by ~ 0.15 pH units. 
The pKa values for the limits of low and high redox potential values differ by 0.2 pH unit for 
each propionate and by 0.15 pH unit for the glutamic acid. Therefore, even though the glutamic 
acid is farther apart from the heme than the propionates, it still significantly interacts with the 
heme group. Thus, for NAcMP8, the pH dependence of the standard redox potential of the heme 
group cannot be completely explained by considering just a single pH-active site or just the heme 
propionates. As an example, for the implicit solvent simulation, using equation 16 we see that the 
GL4 residue contributes with 8.8 mV to the difference of 28.6 mV between the Eo values for the 
limits when the pH-active residues are fully protonated and fully deprotonated. 
As both in the implicit and explicit solvent calculations the protonation and redox state change 
attempts were performed using the same GB model, the differences between our IS and ES 
simulations on the relative Eo and pKa predictions in comparison to the reference compound can 
only come from the different ensemble of configurations generated in both cases. Figure 7 shows 
these conformational differences are significant enough to produce different Eo and pKa values in 
IS and ES, even though the overall trends are the same. The pKa predictions are ~ 0.5 pH units 
higher in ES than in IS. Also, even though the Eo values at low pH limits are basically the same, 
at the high pH limit Eo is ~ 12 mV lower in ES than in IS. In addition, as one would expect from 
Figure 5, we can also observe the influence of the total number of MD steps by comparing 
Figure 7 with the results for short simulations shown in Figure 4.  
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For consistency, it is important to compare the low and high pH limiting Eo values with the Eo 
values predicted using E-REMD for the same EAF and same total number of steps but without 
the constant pH option. Without using constant pH, the Eo values obtained when all pH-active 
residues are protonated and deprotonated are respectively -178.55 and -207.95 mV in IS, and -
176.98 and -214.86 mV in ES. When constant pH is used, the Eo values for the low and high pH 
limits are respectively -179.18 and -207.93 mV in IS and -177.69 and -214.58 mV in ES. The 
agreement between the Eo predictions is good, as the predictions agree within less than 1 mV. 
By considering a model where the pH-dependence of the heme group is associated to a single 
pH-active group, Das and Medhi 53 were able to experimentally infer for microperoxidase 11 the 
pKa values that correspond to the heme being fully reduced and fully oxidized. Microperoxidase 
11 differs from NAcMP8 for having an extended peptide chain which contains a pH-active lysine 
reside. Also, the axial ligand in their experiments is a water molecule, instead of a histidine as is 
our case. Using their single pH-residue model for the range of pH values between 5.0 and 7.5 
they obtained pKa values of 7.1 and 6.3 when the heme group is reduced and oxidized, 
respectively. According to equation 16, the difference between these pKa values should be 
directly related to the difference of Eo values for when the pH-active group is fully protonated 
and fully deprotonated. From our ES simulations, the pKa values for both propionates at the low 
and high redox potential limits corresponding to the heme being fully reduced and fully oxidized 
are, respectively, 6.65 and 6.45 for PNR 15 and 6.80 and 6.60 for PNR 16. Assuming the 
experimental pKa values of 7.1 and 6.3 to correspond to the heme propionates, we see that the 
propionate pKas values obtained in our simulations are in the same range as the experimental 
ones. 
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In another publication 54, Das and Medhi were also able to experimentally infer for several 
different proteins the pKa values that would correspond to the heme propionates. For cytochrome 
c2, they obtained pKa values of 7.4 and 6.3 when the heme group is reduced and oxidized, 
respectively. For cytochrome b5, where the propionates are more solvent exposed, they obtained 
pKa values are 5.9 and 5.7. We see the propionate pKa values obtained in our simulations are in 
the same range as the experimental ones for cytochrome c2. As can be seen in Figure 2, the 
propionates on NAcMP8 are solvent exposed. As Figure 7 shows, the ΔpKa for each propionate 
when the heme group fully reduced and fully oxidized is 0.2. This difference matches with the 
one obtained experimentally for cytochrome b5 where the propionates are mostly solvent 
exposed. However, this comparison should not be over interpreted as in the experimental paper 
only a single pH-active residue was considered in their model, where in our simulations 3 pH-
active residues are considered. 
D. Computational Benchmarks 
In Table 1 the computational efficiency of the pmemd and sander AMBER modules is compared 
for C(pH,E)MD. Calculations were done using Cray XK7 nodes (that have Tesla K20X GPUs) at 
the Blue Waters supercomputer. In implicit solvent, there are 237 atoms (corresponding to the 
NAcMP8 and the histidine peptide) and in explicit solvent this number is 7403 atoms (there are 
2388 water molecules and 2 Na+ ions). The calculations were performed for pH = 7.0 and E =
−203 mV. 
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 Implicit Solvent Explicit Solvent 
Computation Computational performance (ns/day) 
sander Serial (1 CPU) 6.38 0.27 
sander MPI (2 CPUs) 13.18 0.55 
sander MPI (4 CPUs) 25.11 1.04 
sander MPI (8 CPUs) 42.98 1.71 
sander MPI (16 CPUs) 75.44 2.78 
pmemd Serial (1 CPU) 4.48 0.52 
pmemd MPI (2 CPUs) 9.40 1.02 
pmemd MPI (4 CPUs) 18.11 1.99 
pmemd MPI (8 CPUs) 31.42 3.30 
pmemd MPI (16 CPUs) 56.95 5.24 
pmemd CUDA SPFP (1 GPU) 336.58 126.56 
pmemd CUDA DPFP (1 GPU) 135.23 59.34 
Table 1. Computational performances of C(pH,E)MD for different sander and pmemd 
computations. 
sander was the first module implemented on AMBER capable of performing molecular 
dynamics. pmemd started as a reimplementation of some sander functionalities, intended to 
improve the computational performance of the simulations. In Table 1, we see that for serial and 
MPI the IS C(pH,E)MD calculations with sander are faster than with pmemd, however for ES, 
where the total number of atoms increases 31 times in comparison to the IS calculations, the 
computational performance is better for pmemd than for sander. This shows the scalability of 
pmemd is better, which means it would perform even better for larger systems in comparison to 
sander. Even though the calculations scale well with the number of CPUs, Table 1 also 
emphasizes the high-performance aspect of the GPU enabled implementation. Great speedups 
are observed in both IS and ES calculations. In ES, we see that the SPFP calculation using GPU 
is 243 times faster than the serial calculation and 24 times faster than the fastest MPI calculation. 
The SPFP precision model is around 2 times faster than the DPFP precision model in the CUDA 
calculations. 
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It is important to mention that the computational cost of our methodology in ES depends on the 
values of E and pH. If the redox potential value is close to the Eo of a redox-active residue or if 
the pH value is close to the pKa of a pH-active residue, the probability of accepting a state 
change attempt increases, and in explicit solvent this means that more relaxation steps will be 
performed. 
In Table 2 we compare the computational cost of E-REMD, C(pH,E)MD, CpHMD, and CEMD 
in comparison to regular MD. Here we have only used the pmemd.cuda_SPFP.MPI module. For 
C(pH,E)MD we performed calculations for 36 (pH,E) values, combining 𝑝𝐻𝑠 =
3.5, 4.0, 4.5, 5.0, 5.5 and 6.0 with 𝐸𝑠 = −263,−233,−203,−173,−143 and −113 mV. For 
CpHMD, CEMD and regular MD we have executed the same simulations as in C(pH,E)MD but 
turning off respectively the constant redox potential, the constant pH, and both the constant 
redox potential and pH. For E-REMD we have performed the same simulations as in 
C(pH,E)MD but allowing the redox potential values between replicas of same pH to be 
exchanged. The computational performances shown in Table 2 are the averages for the 36 (pH,E) 
simulations. 
 Implicit Solvent Explicit Solvent 
Calculation Computational performance (ns/day) 
Regular MD 491.86 225.32 
CpHMD 391.55 154.74 
CEMD 389.62 163.83 
C(pH,E)MD 289.13 145.08 
E-REMD at CpH 
(EAF = 0.5 ps-1) 
275.68 103.54 
E-REMD at CpH 
(EAF = 50 ps-1 IS and 5 ps-1 ES) 
198.10 96.81 
Table 2. Computational performances of pmemd.cuda_SPFP.MPI for different calculations. 
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As Table 2 shows, the addition of constant pH and/or constant redox potential has a bearable 
computational cost in comparison to regular MD. CpHMD and CEMD are 21% slower in IS and 
around 30% slower in ES than regular MD. In IS, the computational performances of CpHMD 
and CEMD are essentially the same. In ES, because each residue is visited once during 
protonation or redox state change attempts, the small difference between CpHMD and CEMD 
performances can be explained by the fact that we have three pH-active residues and only one 
redox-active residue. C(pH,E)MD is 41% slower in IS and 36% slower in ES than regular MD. 
We observe that the C(pH,E)MD performance is close to the CpHMD and CEMD performances 
for ES. 
At the section IV.B we discussed the effect of increasing the EAF in our E-REMD simulations. 
As can be seen at Table 2, the computational cost of the simulation raises when EAF is 
increased, mainly in implicit solvent. The addition of replica exchange has a bearable 
computational cost in comparison to C(pH,E)MD. For the largest EAF we used, E-REMD is 
31% slower in IS and 33% slower in ES than C(pH,E)MD. 
V. CONCLUSIONS 
Based on the existing CpHMD and pH-REMD methods 13,18,25 implemented by Mongan, Swails, 
and others, we have successfully implemented the CEMD, C(pH,E)MD and E-REMD methods 
in AMBER. These methods allow the theoretical study of systems at a constant value of redox 
potential, using both implicit and explicit solvent models. 
Validation results and tests were presented for NAcMP8 axially connected to a histidine peptide. 
This system contains a single heme and three pH-active residues. Our simulations correctly 
describe the behavior of Eo vs pH and of pKa vs redox potential, in good agreement with 
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theoretical predictions. Regarding the NAcMP8’s heme group, for the complete description of 
the pH dependence of its Eo we conclude it is necessary to consider more than one pH-active 
group, as both propionates and also the glutamic acid interact significantly with the heme. We 
observed that the propionates have slightly different pKa values (a difference of ~0.15 pH units) 
and that these pKa values are in agreement with values obtained experimentally for other proteins 
that contain a single heme. 
The addition of replica exchange significantly improves the statistical convergence of our Eo 
predictions. The increase in the exchange attempt frequency in our replica exchange simulations 
did not show a significant change in the convergence efficiency of our calculations. The smallest 
EAF used (0.005ps-1) was already satisfactory to reproduce effectively the same convergence as 
the larger EAF used. 
Based on our computational benchmarks, we see that our methodologies have an acceptable 
computational cost in comparison to regular MD and that the GPU-accelerated code is able to 
provide high-performance in comparison to calculations using CPUs. 
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